ImmunityBio, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.68B +98.1% €913.40M +384.1% 54.2% +0.32 pp N/A N/A
    (estimated) €850.50M +91.9% €188.66M -331.7% 22.2% +0.41 pp N/A N/A
    (estimated) €443.19M +132.2% -€81.43M -69.6% -18.4% +1.2 pp N/A N/A
    (estimated) €190.83M +101.1% -€268.03M -24.8% -140.5% +2.4 pp N/A N/A
    (estimated) €94.91M +647.1% -€356.62M +0.1% -375.8% +24 pp N/A N/A
    €12.70M +2,270.6% -€356.31M -29.1% -2,804.8% +910 pp -€331.13M +14.3% -2,606.6% +510 pp
    €535.88K +159.2% -€502.45M +39.7% -93,761.4% +800 pp -€289.63M +41.2% -54,047.1% +450 pp
    €206.77K -74.3% -€359.54M +19.3% -173,883.3% -1.4K pp -€205.15M -1.1% -99,215.8% -730 pp
    €804.69K +54.4% -€301.41M +56.1% -37,457.0% -4.0 pp -€207.51M +41.6% -25,787.6% +23 pp
    €521.24K -72.5% -€193.15M +40.0% -37,055.7% -300 pp -€146.51M +15.0% -28,108.3% -210 pp
    €1.90M +4,585.1% -€137.98M +66.4% -7,273.3% +2.0K pp -€127.36M +194.0% -6,713.1% +1.0K pp
    €40.49K +4.4% -€82.90M -0.2% -204,736.2% +95 pp -€43.32M +260.0% -106,976.6% -760 pp
    €38.77K +2.3% -€83.07M -20.2% -214,273.3% +600 pp -€12.03M -56.4% -31,033.3% +420 pp
    €37.91K -81.4% -€104.08M -49.0% -274,565.9% -1.7K pp -€27.60M +38.9% -72,802.3% -630 pp
    €203.33K -63.2% -€204.08M +3,712.6% -100,371.2% -990 pp -€19.87M +356.3% -9,772.9% -90 pp
    €552.25K +6.8% -€5.35M +203.5% -969.3% -6.3 pp -€4.36M +660.2% -788.6% -6.8 pp
    €516.93K -€1.76M -341.2% -€572.93K -110.8%

    Notifications